Comparative cost-effectiveness analysis of oral triptan therapy for migraine in four European countries. [electronic resource]
- The European journal of health economics : HEPAC : health economics in prevention and care May 2014
- 433-7 p. digital
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
1618-7601
10.1007/s10198-013-0516-x doi
Administration, Oral Cost-Benefit Analysis Decision Trees Europe Humans Migraine Disorders--drug therapy Tryptamines--administration & dosage